ReachLocal to Report First Quarter 2016 Results and Host Quarterly Conference Call on May 3
Apr 19, 2016 13:15 pm UTC| Business
WOODLAND HILLS, Calif., April 19, 2016 -- ReachLocal, Inc. (NASDAQ:RLOC), a leader in powering online marketing for local businesses, today announced it will report its first quarter 2016 financial results for the...
CFPB Compliance Drives Increased Costs
Apr 19, 2016 13:15 pm UTC| Business
ALPHARETTA, Ga., April 19, 2016 -- Since the Consumer Financial Protection Bureau (CFPB) began regulation and enforcement in 2010, 86 percent of financial services professionals have seen an increase in regulatory...
AACR Research Reception Featured Late-Breaking Poster on Lm Technology™ Platform
Apr 19, 2016 13:05 pm UTC| Business
Reception included update on the Company’s MINE program(My Immunotherapy Neo-Epitopes) /ADXS-NEO immunotherapy STING Pathway and Advaxis’ Lm Technology™ highlighted Slides and audio are available online on the Company’s...
Apr 19, 2016 13:05 pm UTC| Business
SAN RAMON, Calif., April 19, 2016 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet...
MacroGenics Presents Data from Five Preclinical Programs at AACR Annual Meeting 2016
Apr 19, 2016 13:05 pm UTC| Business
ROCKVILLE, Maryland, April 19, 2016 -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the...
Apr 19, 2016 13:05 pm UTC| Business
TORONTO and SAN DIEGO, April 19, 2016 -- Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2 proof-of-concept, today announced positive results...
Apr 19, 2016 13:01 pm UTC| Business
Poster demonstrates novel approach to a universal T cell overcoming key challenges of current chimeric antigen receptor (CAR) technologies/therapiesPotentially meaningful application of SMDC platform in immuno-oncology ...